Jennifer L Hsiao, MD

Clinical Professor of Dermatology (Clinician Educator)

Image of Jennifer L Hsiao, MD
Is this your profile? Click to edit

Publications

  • Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials. Nat Med. 2026 Jul 23.. View in PubMed
  • American Academy of Dermatology 2026 Annual Meeting: Updates in Hidradenitis Suppurativa Medical Management. Dermatol Ther (Heidelb). 2026 Jul 09.. View in PubMed
  • A Systematic Review of Factors Influencing Adult Adherence to Topical Medications in Atopic Dermatitis. Am J Clin Dermatol. 2026 Jul 09.. View in PubMed
  • Increased Risk of Deep Vein Thrombosis and Pulmonary Embolism in Hidradenitis Suppurativa Patients With Down Syndrome: A Retrospective Cohort Study. Int J Dermatol. 2026 Jun 29.. View in PubMed
  • The Impact of Chronic Spontaneous Urticaria on Sleep-A Systematic Review. Dermatol Ther (Heidelb). 2026 Jun 29.. View in PubMed
  • Application Site Adverse Events of Topical Nonsteroidal Immunomodulators: A Post-Marketing Analysis of the FDA Adverse Event Reporting System. Int J Dermatol. 2026 Jun 28.. View in PubMed
  • Criteria for Hidradenitis Suppurativa Competence Centers. Dermatol Ther (Heidelb). 2026 Jul; 16(7):3445-3460.. View in PubMed
  • Povorcitinib for Hidradenitis suppurativa: a narrative review on clinical trial data with expert commentary. Expert Opin Pharmacother. 2026 Jul; 27(10):1019-1027.. View in PubMed
  • Symposium on Hidradenitis Suppurativa Advances 2025 Proceedings. Dermatol Ther (Heidelb). 2026 Jun; 16(6):2587-2601.. View in PubMed
  • Global barriers to sexual health, pregnancy, and breastfeeding in hidradenitis suppurativa. Int J Womens Dermatol. 2026 Jun; 12(2):e261.. View in PubMed
  • Exploring the Impact of Fatigue and Sleep Disturbance in Hidradenitis Suppurativa: Perspectives from Patients and Healthcare Professionals. Acta Derm Venereol. 2026 Apr 16; 106.. View in PubMed
  • A case of eosinophilic dermatosis of hematologic malignancy treated with omalizumab. JAAD Case Rep. 2026 Jun; 72:131-134.. View in PubMed
  • Health System Experiences and Care Engagement in Latine Patients With Hidradenitis Suppurativa. JAMA Dermatol. 2026 Feb 01; 162(2):151-156.. View in PubMed
  • An Update to Ethnoracial Gaps in Global Hidradenitis Suppurativa Clinical Trials. Skin Appendage Disord. 2026 Jan 14.. View in PubMed
  • Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi Approach. JAMA Dermatol. 2026 Jan 01; 162(1):72-79.. View in PubMed
  • Combination Ablative Fractional CO 2 Laser, Intense Pulsed Light, and Triamcinolone for the Management of Hidradenitis Suppurativa: A Case Series. Adv Skin Wound Care. 2026 Jan-Feb 01; 39(1):E57-E61.. View in PubMed
  • Dual Targeted Therapy for Hidradenitis Suppurativa: A Narrative Review. Dermatol Ther (Heidelb). 2026 Jan; 16(1):231-245.. View in PubMed
  • The HIdradenitis suppurativa DrainagE (HIDE) scale: development and content validation of a patient reported outcome measure. Br J Dermatol. 2025 Nov 18; 193(6):1242-1244.. View in PubMed
  • Dual immunomodulator therapy with upadacitinib and bimekizumab in severe hidradenitis suppurativa: A case report. JAAD Case Rep. 2026 Jan; 67:155-157.. View in PubMed
  • Allergenicity and Unregulated Marketing Claims in Tinted Sunscreens. Dermatitis. 2025 Sep 23; 17103568251382236.. View in PubMed
  • Letter: Lip Sunscreens: Analysis of Allergenicity and Marketing Claims. Dermatitis. 2026 Mar-Apr; 37(2):e287-e289.. View in PubMed
  • Physicochemical properties of tinted sunscreens and practical considerations. J Am Acad Dermatol. 2025 Dec; 93(6):1621-1623.. View in PubMed
  • Utilizing the Patient Health Questionnaire (PHQ-2) as a depression screening tool for patients with hidradenitis suppurativa. Int J Womens Dermatol. 2025 Oct; 11(3):e223.. View in PubMed
  • Hidden UV filters: An analysis of the 150 most popular sunscreens. J Am Acad Dermatol. 2025 Dec; 93(6):1594-1596.. View in PubMed
  • Factors Influencing Treatment Adherence in Chronic Spontaneous Urticaria: A Systematic Review. Clin Rev Allergy Immunol. 2025 Jul 30; 68(1):74.. View in PubMed
  • Current Treatments and Future Directions for Hidradenitis Suppurativa: a Narrative Review of Completed and Ongoing Phase 3 Clinical Trials of Biologic Therapies. Dermatol Ther (Heidelb). 2025 Sep; 15(9):2361-2377.. View in PubMed
  • Ethnoracial and Geographic Disparities in Global Atopic Dermatitis Clinical Trials: An Update. Dermatology. 2025; 241(4):410-414.. View in PubMed
  • New onset hidradenitis suppurativa and eruptive milia associated with gamma secretase inhibitor therapy in a patient with desmoid tumor: A case report. JAAD Case Rep. 2025 Sep; 63:81-83.. View in PubMed
  • Dissecting Cellulitis of the Scalp: A Retrospective Cohort Study of Demographics, Provider Landscape, and Comorbidities. Int J Dermatol. 2026 Mar; 65(3):575-577.. View in PubMed
  • A Review of Cutaneous Extraintestinal Manifestations of Inflammatory Bowel Disease in Skin of Color. Inflamm Bowel Dis. 2025 Jun 13; 31(6):1702-1715.. View in PubMed
  • Dissecting cellulitis of the scalp: Treatment responses in a retrospective cohort study. J Am Acad Dermatol. 2025 Oct; 93(4):1101-1103.. View in PubMed
  • Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn Disease: A Consensus Statement. JAMA Dermatol. 2025 06 01; 161(6):642-647.. View in PubMed
  • Hyperhidrosis Clinical Trial Disparities: Enrollment and Reporting Trends. Skin Appendage Disord. 2025 Dec; 11(6):498-502.. View in PubMed
  • Bibliometric Analysis in Hyperhidrosis: Recent Publication Trends from 2015 to 2025. Skin Appendage Disord. 2025 Dec; 11(6):560-575.. View in PubMed
  • Correction to: Adherence to Hidradenitis Suppurativa Treatment. Am J Clin Dermatol. 2025 May; 26(3):475.. View in PubMed
  • Postmarketing safety analysis of upadacitinib in atopic dermatitis: A Food and Drug Administration adverse reporting system review of boxed warning-related adverse events. J Am Acad Dermatol. 2025 Aug; 93(2):479-481.. View in PubMed
  • Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts. Am J Clin Dermatol. 2025 Jul; 26(4):487-497.. View in PubMed
  • A Guide to the Management of Hidradenitis Suppurativa in Pregnancy and Lactation. Am J Clin Dermatol. 2025 May; 26(3):345-360.. View in PubMed
  • National Institutes of Health Dermatology Funding Trends: 2020-2024. J Invest Dermatol. 2025 Oct; 145(10):2629-2632.. View in PubMed
  • Postmarketing safety surveillance of adalimumab, secukinumab, and infliximab in hidradenitis suppurativa: an analysis of the FDA adverse events reporting system (FAERS) database. J Am Acad Dermatol. 2025 Jun; 92(6):1434-1435.. View in PubMed
  • Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report. Skin Health Dis. 2025 Feb; 5(1):66-69.. View in PubMed
  • Response to “Hidradenitis suppurativa electronic medical record (EPIC) tool: A convenient tool of hidradenitis suppurativa specialty clinics”. JAAD Int. 2025 Apr; 19:65-66.. View in PubMed
  • Hidradenitis Suppurativa in Children. Dermatol Clin. 2025 Apr; 43(2):317-330.. View in PubMed
  • Lifestyle Modifications and Nonpharmacological Treatments in Hidradenitis Suppurativa. Dermatol Clin. 2025 Apr; 43(2):273-284.. View in PubMed
  • North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations. J Am Acad Dermatol. 2025 04; 92(4):825-852.. View in PubMed
  • Sexual Dysfunction in Chronic Urticaria: A Systematic Review. Dermatol Ther (Heidelb). 2025 Jan; 15(1):31-44.. View in PubMed
  • Navigating the current revolution in hidradenitis suppurativa care and research. J Am Acad Dermatol. 2024 Dec; 91(6S):S1-S2.. View in PubMed
  • Biologic Use During Pregnancy and Breastfeeding in Dermatology: An Evidence-Based Review. J Drugs Dermatol. 2024 Nov 01; 23(11):1010-1015.. View in PubMed
  • Innovations in Hidradenitis Suppurativa. Dermatol Clin. 2025 Jan; 43(1):35-53.. View in PubMed
  • Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review. Pediatr Dermatol. 2024 Nov-Dec; 41(6):1077-1090.. View in PubMed
  • Analysis of Ingredients, Safety Hazards, and Marketing Claims of Popular Insect Repellents. Dermatitis. 2024 Nov-Dec; 35(6):653-654.. View in PubMed
  • A Review of Hidradenitis Suppurativa in Special Populations: Considerations in Children, Pregnant and Breastfeeding Women, and the Elderly. Dermatol Ther (Heidelb). 2024 Sep; 14(9):2407-2425.. View in PubMed
  • Hidradenitis suppurativa is associated with inflammatory arthritis, systemic lupus erythematosus, and other autoimmune diseases: A retrospective population-level study. JAAD Int. 2024 Dec; 17:55-57.. View in PubMed
  • Readability of Information Generated by ChatGPT for Hidradenitis Suppurativa. JMIR Dermatol. 2024 08 14; 7:e55204.. View in PubMed
  • New insights on hidradenitis suppurativa phenotypes and treatment response: An exploratory automated analysis of the SUNSHINE and SUNRISE trials. J Eur Acad Dermatol Venereol. 2025 Aug; 39(8):1410-1420.. View in PubMed
  • Advances in Hidradenitis Suppurativa Pathogenesis and Therapies from the Symposium on HS Advances 2023. J Invest Dermatol. 2024 08; 144(8):1681-1684.. View in PubMed
  • Hurley Staging Training for Hidradenitis Suppurativa Patients. Skin Appendage Disord. 2024 Dec; 10(6):524-527.. View in PubMed
  • Ustekinumab in Hidradenitis Suppurativa: A Systematic Review and Meta-analysis. Dermatol Ther (Heidelb). 2024 Jul; 14(7):1901-1916.. View in PubMed
  • Adherence to Hidradenitis Suppurativa Treatment. Am J Clin Dermatol. 2024 Jul; 25(4):585-594.. View in PubMed
  • Racial and geographic disparities in global prurigo nodularis clinical trials. Int J Dermatol. 2024 Oct; 63(10):e259-e261.. View in PubMed
  • Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study. Cutis. 2024 Jun; 113(6):251-254.. View in PubMed
  • The top 100 most cited articles in urticaria: a bibliometric analysis. Arch Dermatol Res. 2024 Jun 01; 316(6):327.. View in PubMed
  • Allergenicity and marketing characteristics of 100 popular over-the-counter acne treatments. Arch Dermatol Res. 2024 May 25; 316(6):276.. View in PubMed
  • Spironolactone in hidradenitis suppurativa: a single-center. Int J Womens Dermatol. 2024 Mar; 10(1):e135.. View in PubMed
  • Pediatric hidradenitis suppurativa publication trends: 2012 to 2022. Pediatr Dermatol. 2024 May-Jun; 41(3):472-475.. View in PubMed
  • Expert Practices in Hidradenitis Suppurativa Flare Management: A Cross-Sectional Survey Study. Skin Appendage Disord. 2024 Jun; 10(3):224-228.. View in PubMed
  • A survey-based study evaluating breastfeeding decisions and their impact on management in patients with hidradenitis suppurativa. J Am Acad Dermatol. 2024 05; 90(5):1023-1025.. View in PubMed
  • No-shows to hidradenitis suppurativa clinic visits: Patient perspectives. Skin Health Dis. 2024 Apr; 4(2):e322.. View in PubMed
  • Patient practices in hidradenitis suppurativa flare management: a cross-sectional survey study. Arch Dermatol Res. 2023 12 04; 316(1):13.. View in PubMed
  • Perspectives of Emergency Medicine Physicians on Hidradenitis Suppurativa Care. Skin Appendage Disord. 2024 Apr; 10(2):133-136.. View in PubMed
  • Top cited articles in dissecting cellulitis of the scalp: A bibliometric analysis. Skin Res Technol. 2023 11; 29(11):e13509.. View in PubMed
  • Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement. JAMA Dermatol. 2023 11 01; 159(11):1258-1266.. View in PubMed
  • Allergens and Marketing Claims of Popular Baby Washes. Dermatitis. 2024 Jul-Aug; 35(4):397-399.. View in PubMed
  • Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm. Dermatol Ther (Heidelb). 2023 Nov; 13(11):2487-2526.. View in PubMed
  • Managing seasonal flares in hidradenitis suppurativa. J Am Acad Dermatol. 2024 01; 90(1):e23-e24.. View in PubMed
  • Perspectives and experiences of primary care providers on hidradenitis suppurativa care. Int J Dermatol. 2024 Feb; 63(2):e60-e62.. View in PubMed
  • Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review. J Drugs Dermatol. 2023 Aug 01; 22(8):785-794.. View in PubMed
  • Efficacy of medical treatments for pediatric hidradenitis suppurativa: A systematic review. Pediatr Dermatol. 2023 Sep-Oct; 40(5):775-788.. View in PubMed
  • Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa-Part II: Procedural and Wound Care Therapies. Dermatol Ther (Heidelb). 2023 Aug; 13(8):1699-1720.. View in PubMed
  • Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies. Dermatol Ther (Heidelb). 2023 Aug; 13(8):1661-1697.. View in PubMed
  • Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study. Dermatology. 2023; 239(5):732-737.. View in PubMed
  • Trimethoprim/sulfamethoxazole and cephalexin combination therapy in hidradenitis suppurativa patients: A series of 16 cases. JAAD Case Rep. 2023 Jul; 37:1-4.. View in PubMed
  • Efficacy of procedural treatments for pediatric hidradenitis suppurativa: A systematic review. Pediatr Dermatol. 2023 Jul-Aug; 40(4):595-605.. View in PubMed
  • Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study. Arch Dermatol Res. 2023 Sep; 315(7):2129-2136.. View in PubMed
  • COVID-19 Infection in Hidradenitis Suppurativa Patients: A Retrospective Study. Skin Appendage Disord. 2023 Jun; 9(3):203-206.. View in PubMed
  • Geospatial analysis of access to dermatology care in Los Angeles County: a cross sectional study. Dermatol Online J. 2023 Feb 15; 29(1).. View in PubMed
  • A practical guide to starting a hidradenitis suppurativa specialty clinic. JAAD Int. 2023 Jun; 11:117-120.. View in PubMed
  • Wound drainage measurements: a narrative review. Arch Dermatol Res. 2023 Sep; 315(7):1863-1874.. View in PubMed
  • Low Rates of Psychosocial Screening and Lifestyle Counseling in Hidradenitis Suppurativa Patients in the USA. Skin Appendage Disord. 2023 Mar; 9(2):94-98.. View in PubMed
  • Atopic Dermatitis: A Guide to Transitioning to Janus Kinase Inhibitors. Dermatitis. 2023 Jul-Aug; 34(4):297-300.. View in PubMed
  • Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data. Dermatol Ther (Heidelb). 2023 Feb; 13(2):581-594.. View in PubMed
  • Integrating primary palliative care into hidradenitis suppurativa management. Int J Womens Dermatol. 2022 Dec; 8(4):e063.. View in PubMed
  • Perspectives of obstetricians/gynecologists on hidradenitis suppurativa care: a survey study. Int J Womens Dermatol. 2022 Dec; 8(4):e064.. View in PubMed
  • Patient perspectives on diagnosis and management of hidradenitis suppurativa: A web-based survey. JAAD Int. 2022 Dec; 9:139-141.. View in PubMed
  • A survey of dermatologist perspectives on disease management of patients with hidradenitis suppurativa. JAAD Int. 2022 Dec; 9:94-96.. View in PubMed
  • Health Literacy in Dermatology Patients: How to Level the Playing Field. Cutis. 2022 09; 110(3):119-120.. View in PubMed
  • Optimizing hidradenitis suppurativa clinic visits: Patient perspectives. Int J Womens Dermatol. 2022 Oct; 8(3):e040.. View in PubMed
  • Allergen Composition, Marketing Claims, and Affordability of Pediatric Sunscreens. Dermatitis. 2022 Nov-Dec 01; 33(6):435-441.. View in PubMed
  • Hidradenitis suppurativa surgery: patient perspectives and barriers. Int J Dermatol. 2023 04; 62(4):e270-e272.. View in PubMed
  • Real-World Considerations of Candidacy for Biologics in Hidradenitis Suppurativa. Am J Clin Dermatol. 2022 Nov; 23(6):749-753.. View in PubMed